|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
What a quarter, Cramer says. He also is fond of Stryker.
Cramer likes how it consistently trims pharmacy costs.
Cramer says the mining company is making money hand-over-fist.
Cramer says it's worth a lot more than what it's selling for.
Cramer says Boston Scientific paid too much for Guidant.
With health stocks at such low prices, now is the time to bet on the needs of the aging generation.
Lawyers claim Johnson & Johnson's artificial disks are prone to painful failures.
The company's new metal implant is supposed to last longer, but safety concerns linger.
The company says its new implant fits women better. But some see mere marketing hype.
The stock's discount should diminish as it works through recent acquisitions.
The conference call spells out exactly how much is going right for this company.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.